- Drugs List
- Therapeutic Indications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
Topical cream containing 0.025% Capsaicin
Relief of pain associated with osteoarthritis
The applications (a small pea sized amount) should be evenly spaced throughout the waking hours 4 times a day and not more than every 4 hours. The cream should be gently rubbed in with no residue left on the surface. Hands should be washed immediately after application unless they are the area being treated.
Pain relief usually begins within the first week of treatment and increases with continuing regular application for the next 2 to 8 weeks.
Apply small amounts to the affected area four times daily, and not more often than every 4 hours.
Children under 18 years
Precautions and Warnings
Contains benzyl alcohol
Contains cetyl alcohol - may cause local skin reactions
Advise patient to wash hands after use
Avoid application before or after a bath or shower
Avoid broken or inflamed skin
Avoid contact with eyes
May cause transient burning particularly if applied more than 4 times a day
Tight bandages should not be used
Advise patient residue on clothing/bedding may cause fire hazard
Advise patient to consult physician if condition worsens / does not improve
Avoid inhalation of vapours from the product
Fire hazard: Keep away from naked flames and potential sources of ignition
Pregnancy and Lactation
Capsaicin cream is considered safe for use during pregnancy.
Although the manufacturer states that safety during pregnancy is not established, given the small amount absorbed following topical administration, it is unlikely that capsaicin will cause any adverse effects.
Use capsaicin cream with caution during breastfeeding.
The manufacturer advises caution if capsaicin cream is used when breastfeeding. The safety of capsaicin cream during lactation has not been established. However, it is unlikely that capsaicin will cause any adverse effects in humans.
Capsaicin cream should not be applied to the breast or other areas where there may be direct contact with the infant's skin as this may cause severe pain to the infant.
Exacerbation of pre-existing asthma
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Summary of Product Characteristics: Zacin Cream 0.025%. Cephalon Limited. Revised November 2020.
US National Library of Medicine. Toxicology Data Network. Drugs and Lactation Database (LactMed).
Available at: https://www.ncbi.nlm.nih.gov/books/NBK501922/
Capsaicin. Last revised: 17 May 2021
Last accessed: 26 July 2021
Already a member? Log in
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.